Institute of Biotechnology
of the Czech Academy of Sciences

The aim of the two-day meeting held on June 2-3 was to evaluate the research results and plans for further activities of six research laboratories, i.e. half of the Institute of Biotechnology operating in the BIOCEV center. Members of the Scientific Advisory Board of the Institute of Biotechnology of the CAS (SAB) and two external members of the IBT Board met for this purpose for the first time since the establishment of the SAB in 2021.

A team of scientists and physicians from the Institute of Biotechnology of the CAS at the BIOCEV centre and the Institute of Clinical and Experimental Medicine in Prague has demonstrated a positive effect of MitoTam on type 2 diabetes. The research was published in the prestigious journal Nature Communications.

A research team led by Professor Jiří Neužil from the Institute of Biotechnology of the Academy of Sciences of the Czech Republic at the BIOCEV center described the effect of the Czech anti-cancer substance MitoTam in combination with immunotherapy on kidney tumors.

Introduce the Centre of Molecular Structure (CMS) and its services to potential users

#ScienceForUkraine is a community group of volunteer students and research scientists from academic institutions in Europe and around the world. Its mission is to collect and disseminate information about support opportunities at the university, national, and international level for graduate students and researchers directly affiliated to an academic institution in Ukraine. ...

In an open letter the Institute of Biotechnology of the Czech Academy of Sciences appeals to Russian scientists to strongly condemn the aggression against Ukraine.

An important aspect of fertilisation in mammals is the protein network communication between the egg and sperm. These protein complexes undergo crucial changes and rearrangements during sperm movement through the female reproductive tract, where sperm maturation takes place.

This year, six group leaders have received EMBO Installation Grants. One of them, and the only recipient in the Czech Republic, is Kateřina Rohlenová from the Institute of Biotechnology AS CR in the BIOCEV centre, who is also a recent holder of a prestigious ERC grant.

Mgr. Katerina Rohlenova, Ph.D. from the Institute of Biotechnology of the Czech Academy of Sciences at the BIOCEV Centre has been awarded the most prestigious European scientific grant by the European Research Council (ERC). She will receive EUR 1.5 million (approximately CZK 38 million) over five years for her innovative research into metabolic communication in tumours.

Testing of samples for the presence of SARS-CoV-2 virus by PCR in the BIOCEV centre is available only for employees of the Czech Academy of Sciences and Charles University who work at the Biotechnology and Biomedicine Centre in Vestec. Interested members of the public, companies and other institutions can use testing centres in the vicinity of BIOCEV and Prague.